(Q44935802)

7 December 2017

title

Post-transfusion hepatitis: impact of non-A, non-B hepatitis surrogate tests. Canadian Post-Transfusion Hepatitis Prevention Study Group (English)

1 reference

Post-transfusion hepatitis

7 December 2017

main subject

1 reference

1 reference

M A Blajchman

1

1 reference

7 December 2017

S B Bull

series ordinal

2

1 reference

7 December 2017

S V Feinman

series ordinal

3

1 reference

7 December 2017

language of work or name

English

0 references

publication date

1 January 1995

1 reference

7 December 2017

1 reference

7 December 2017

volume

345

1 reference

7 December 2017

issue

8941

1 reference

7 December 2017

page(s)

21-25

1 reference

Anti-HCV in post-transfusion hepatitis: deductions from a prospective study

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991153-7

7 January 2021

The risk of transfusion-transmitted infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991153-7

7 January 2021

Donor self-exclusion patterns and human immunodeficiency virus antibody test results over a twelve-month period

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991153-7

7 January 2021

Serum alanine aminotransferase of donors in relation to the risk of non-A,non-B hepatitis in recipients: the transfusion-transmitted viruses study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991153-7

7 January 2021

Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991153-7

7 January 2021

Genetic organization and diversity of the hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991153-7

7 January 2021

Hepatitis B virus and apparent fulminant non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991153-7

7 January 2021

Importance of primer selection for the detection of hepatitis C virus RNA with the polymerase chain reaction assay

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991153-7

7 January 2021

The determination of sample sizes for trials involving several independent 2 × 2 tables

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991153-7

7 January 2021

Interim analyses in randomized clinical trials: ramifications and guidelines for practitioners.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991153-7

7 January 2021

Post-Transfusion Hepatitis C Virus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991153-7

7 January 2021

The Declining Risk of Post-Transfusion Hepatitis C Virus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991153-7

7 January 2021

The incidence of post-transfusion hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991153-7

7 January 2021

10.1016/S0140-6736(95)91153-7

Identifiers

DOI

1 reference

7 December 2017

1 reference